Julie M. Gastier‐Foster

79.2k total citations · 2 hit papers
122 papers, 22.8k citations indexed

About

Julie M. Gastier‐Foster is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Hematology. According to data from OpenAlex, Julie M. Gastier‐Foster has authored 122 papers receiving a total of 22.8k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Public Health, Environmental and Occupational Health, 37 papers in Molecular Biology and 37 papers in Hematology. Recurrent topics in Julie M. Gastier‐Foster's work include Acute Lymphoblastic Leukemia research (56 papers), Childhood Cancer Survivors' Quality of Life (23 papers) and Chronic Myeloid Leukemia Treatments (22 papers). Julie M. Gastier‐Foster is often cited by papers focused on Acute Lymphoblastic Leukemia research (56 papers), Childhood Cancer Survivors' Quality of Life (23 papers) and Chronic Myeloid Leukemia Treatments (22 papers). Julie M. Gastier‐Foster collaborates with scholars based in United States, Canada and Switzerland. Julie M. Gastier‐Foster's co-authors include Elaine Lyon, Madhuri Hegde, Sherri J. Bale, Sue Richards, Wayne W. Grody, Heidi L. Rehm, Karl V. Voelkerding, Elaine Spector, David Bick and Nazneen Aziz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Julie M. Gastier‐Foster

118 papers receiving 22.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

2015 18.9k citations Sue Richards, Nazneen Aziz et al. Genetics in Medicine profile →
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group

2021 249 citations Meredith S. Irwin, Arlene Naranjo et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julie M. Gastier‐Foster United States	36	10.4k	9.0k	2.2k	2.2k	2.1k	122	22.8k
Sue Richards United Kingdom	33	9.6k 0.9×	8.7k 1.0×	1.8k 0.8×	2.1k 1.0×	1.6k 0.8×	85	22.4k
Elaine Lyon United States	30	10.9k 1.0×	10.3k 1.1×	2.3k 1.0×	2.2k 1.0×	1.7k 0.8×	102	23.2k
Madhuri Hegde United States	35	11.5k 1.1×	10.7k 1.2×	2.6k 1.2×	2.4k 1.1×	1.7k 0.8×	138	23.8k
David Bick United States	31	10.4k 1.0×	10.3k 1.1×	1.8k 0.8×	2.1k 1.0×	1.5k 0.7×	83	22.0k
Sherri J. Bale United States	52	14.7k 1.4×	12.9k 1.4×	2.9k 1.3×	2.4k 1.1×	1.9k 0.9×	142	29.9k
Nazneen Aziz United States	9	9.4k 0.9×	8.8k 1.0×	1.9k 0.8×	2.1k 1.0×	1.5k 0.7×	9	19.7k
Elaine Spector United States	26	10.1k 1.0×	9.0k 1.0×	1.7k 0.8×	2.1k 1.0×	1.5k 0.7×	71	20.6k
Ad Geurts van Kessel Netherlands	63	8.0k 0.8×	4.8k 0.5×	1.9k 0.8×	318 0.1×	2.9k 1.4×	256	15.6k
Peter C. Harris United States	85	15.8k 1.5×	18.5k 2.1×	465 0.2×	1.1k 0.5×	3.2k 1.5×	383	25.4k
Clair A. Francomano United States	54	4.2k 0.4×	6.2k 0.7×	1.0k 0.5×	1.2k 0.5×	1.7k 0.8×	168	11.0k

Countries citing papers authored by Julie M. Gastier‐Foster

Since Specialization

Citations

This map shows the geographic impact of Julie M. Gastier‐Foster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie M. Gastier‐Foster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie M. Gastier‐Foster more than expected).

Fields of papers citing papers by Julie M. Gastier‐Foster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie M. Gastier‐Foster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie M. Gastier‐Foster. The network helps show where Julie M. Gastier‐Foster may publish in the future.

Co-authorship network of co-authors of Julie M. Gastier‐Foster

This figure shows the co-authorship network connecting the top 25 collaborators of Julie M. Gastier‐Foster. A scholar is included among the top collaborators of Julie M. Gastier‐Foster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie M. Gastier‐Foster. Julie M. Gastier‐Foster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Velu, Priya, Allison M. Cushman‐Vokoun, Mark D. Ewalt, et al.. (2022). Alignment of Fellowship Training with Practice Patterns for Molecular Pathologists. Journal of Molecular Diagnostics. 24(8). 825–840. 1 indexed citations

Reglero, Clara, Chelsea L. Dieck, Arie Zask, et al.. (2022). Pharmacologic Inhibition of NT5C2 Reverses Genetic and Nongenetic Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia. Cancer Discovery. 12(11). 2646–2665. 6 indexed citations

Burke, Michael J., Meenakshi Devidas, Zhiguo Chen, et al.. (2021). Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children’s Oncology Group Study AALL0232. Leukemia. 36(3). 648–655. 12 indexed citations

Mattano, Leonard A., Meenakshi Devidas, Kelly W. Maloney, et al.. (2021). Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331. Journal of Clinical Oncology. 39(14). 1540–1552. 22 indexed citations

Avenarius, Matthew R., Cecelia Miller, Michael Arnold, et al.. (2020). Genetic Characterization of Pediatric Sarcomas by Targeted RNA Sequencing. Journal of Molecular Diagnostics. 22(10). 1238–1245. 11 indexed citations

Wendorff, Agnieszka A., S. Aidan Quinn, Marissa Rashkovan, et al.. (2018). Phf6 Loss Enhances HSC Self-Renewal Driving Tumor Initiation and Leukemia Stem Cell Activity in T-ALL. Cancer Discovery. 9(3). 436–451. 52 indexed citations

McCall, Shannon J., Philip A. Branton, Victoria M. Blanc, et al.. (2018). The College of American Pathologists Biorepository Accreditation Program: Results from the First 5 Years. Biopreservation and Biobanking. 16(1). 16–22. 20 indexed citations

Rudzinski, Erin R., James R. Anderson, Yueh‐Yun Chi, et al.. (2017). Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group. Pediatric Blood & Cancer. 64(12). 65 indexed citations

Campbell, Kevin, Julie M. Gastier‐Foster, Arlene Naranjo, et al.. (2017). Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group. Cancer. 123(21). 4224–4235. 95 indexed citations

10.

Larsen, Eric, Meenakshi Devidas, Si Chen, et al.. (2016). Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232. Journal of Clinical Oncology. 34(20). 2380–2388. 231 indexed citations

11.

Hingorani, Pooja, Edoardo Missiaglia, Janet Shipley, et al.. (2015). Clinical Application of Prognostic Gene Expression Signature in Fusion Gene–Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group. Clinical Cancer Research. 21(20). 4733–4739. 17 indexed citations

12.

Richards, Sue, Nazneen Aziz, Sherri J. Bale, et al.. (2015). Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine. 17(5). 405–424. 18892 indexed citations breakdown →

13.

Thrush, Devon Lamb, Scott E. Hickey, Sayaka Hashimoto, et al.. (2014). Atypical breakpoint in a t(6;17) translocation case of acampomelic campomelic dysplasia. European Journal of Medical Genetics. 57(7). 315–318. 6 indexed citations

14.

Mattano, Leonard A., Meenakshi Devidas, Alison M. Friedmann, et al.. (2014). Outstanding Outcome for Children with Standard Risk-Low (SR-Low) Acute Lymphoblastic Leukemia (ALL) and No Benefit to Intensified Peg-Asparaginase (PEG-ASNase) Therapy: Results of Children’s Oncology Group (COG) Study AALL0331. Blood. 124(21). 793–793. 13 indexed citations

15.

Rudzinski, Erin R., Lisa A. Teot, James R. Anderson, et al.. (2013). Dense Pattern of Embryonal Rhabdomyosarcoma, a Lesion Easily Confused With Alveolar Rhabdomyosarcoma. American Journal of Clinical Pathology. 140(1). 82–90. 66 indexed citations

16.

Pfau, Ruthann, Devon Lamb Thrush, Dennis Bartholomew, et al.. (2013). MCPH1 deletion in a newborn with severe microcephaly and premature chromosome condensation. European Journal of Medical Genetics. 56(11). 609–613. 9 indexed citations

17.

Duan, Fenghai, Lynette M. Smith, Roddy S. O’Connor, et al.. (2011). Genomic and Clinical Analysis of Amplification of the 13q31 Chromosomal Region in Alveolar Rhabdomyosarcoma: A Report from the Children's Oncology Group. Clinical Cancer Research. 17(6). 1463–1473. 50 indexed citations

18.

Kalman, Lisa V., Jay Leonard, Norman P. Gerry, et al.. (2011). Quality Assurance for Duchenne and Becker Muscular Dystrophy Genetic Testing. Journal of Molecular Diagnostics. 13(2). 167–174. 18 indexed citations

19.

Al‐Kateb, Hussam, et al.. (2010). Molecular characterization of a novel, de novo, cryptic interstitial deletion on 19p13.3 in a child with a cutis aplasia and multiple congenital anomalies. American Journal of Medical Genetics Part A. 152A(12). 3148–3153. 10 indexed citations

20.

Moran, Lisa M., H. Gerry Taylor, Kalaichelvi Ganesalingam, et al.. (2009). Apolipoprotein E4 as a Predictor of Outcomes in Pediatric Mild Traumatic Brain Injury. Journal of Neurotrauma. 26(9). 1489–1495. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact